Invention Grant
- Patent Title: Compounds effecting glucokinase
- Patent Title (中): 影响葡萄糖激酶的化合物
-
Application No.: US12363899Application Date: 2009-02-02
-
Publication No.: US07951830B2Publication Date: 2011-05-31
- Inventor: Scott Boyd , Peter William Rodney Caulkett , Rodney Brian Hargreaves , Suzanne Saxon Bowker , Roger James , Clifford David Jones , Darren McKerrecher , Michael Howard Block , Craig Johnstone
- Applicant: Scott Boyd , Peter William Rodney Caulkett , Rodney Brian Hargreaves , Suzanne Saxon Bowker , Roger James , Clifford David Jones , Darren McKerrecher , Michael Howard Block , Craig Johnstone
- Applicant Address: SE Sodertalje
- Assignee: AstraZeneca AB
- Current Assignee: AstraZeneca AB
- Current Assignee Address: SE Sodertalje
- Agency: Morgan Lewis & Bockius LLP
- Priority: SE0102764 20010817
- Main IPC: A61K31/425
- IPC: A61K31/425 ; A61K31/415 ; A61K31/496 ; A61K31/433
Abstract:
The invention relates to the use of a compound of Formula (I) or a salt, solvate or prodrug thereof, wherein R1, R2, R3, n and m are as described in the specification, in the preparation of a medicament for the treatment or prevention of a disease condition mediated through glucokinase (GLK), such as type 2 diabetes. The invention also relates to a novel group of compounds of Formula (I) and to methods for preparing compounds of Formula (I).
Public/Granted literature
- US20090227592A1 COMPOUNDS EFFECTING GLUCOKINASE Public/Granted day:2009-09-10
Information query
